Trends from the National Cancer Database show that the use of neoadjuvant systemic therapy (NST) has increased sharply over the past decade but not uniformly across cancer types or stages. Test your...
Trends from the National Cancer Database show that the use of neoadjuvant systemic therapy (NST) has increased sharply over the past decade but not uniformly across cancer types or stages. Test your...
Trends from the National Cancer Database show that the use of neoadjuvant systemic therapy (NST) has increased sharply over the past decade but not uniformly across cancer types or stages. Test your...
Trends from the National Cancer Database show that the use of neoadjuvant systemic therapy (NST) has increased sharply over the past decade but not uniformly across cancer types or stages. Test your...
Trends from the National Cancer Database show that the use of neoadjuvant systemic therapy (NST) has increased sharply over the past decade but not uniformly across cancer types or stages. Test your...
According to research published in JAMA Surgery, missed opportunities for risk assessment and surgical prevention are common among ovarian cancer patients with high-grade serous cancer (HGSC). Take this...
According to research published in JAMA Surgery, missed opportunities for risk assessment and surgical prevention are common among ovarian cancer patients with high-grade serous cancer (HGSC). Take this...
According to research published in JAMA Surgery, missed opportunities for risk assessment and surgical prevention are common among ovarian cancer patients with high-grade serous cancer (HGSC). Take this...
According to research published in JAMA Surgery, missed opportunities for risk assessment and surgical prevention are common among ovarian cancer patients with high-grade serous cancer (HGSC). Take this...
Telehealth adoption accelerated rapidly during and after the COVID-19 pandemic, raising concerns that greater convenience might drive higher outpatient utilization. However, recent evidence from Medicare...
